Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 1 to 15 of 18 results for extracorporeal membrane oxygenation

  1. Venoarterial extracorporeal membrane oxygenation (VA ECMO) for acute heart failure in adults

    In development [GID-IPG10411] Expected publication date: 06 August 2025

    Interventional procedures guidance
    In development

  2. Extracorporeal membrane oxygenation (ECMO) in postneonatal children (IPG38)

    Evidence-based recommendations on extracorporeal membrane oxygenation in postneonatal children. This involves connecting the child's internal circulation to an external blood pump and artificial lung.

    Interventional procedures guidance
    Published
    28 January 2004
    View recommendations

    Sections for IPG38

  3. Extracorporeal membrane oxygenation for severe acute respiratory failure in adults (IPG391)

    Evidence-based recommendations on extracorporeal membrane oxygenation for severe acute respiratory failure in adults. This involves using a tube to carry blood from the right side of the heart and then pump it through an artificial lung where it picks up oxygen.

    Interventional procedures guidance
    Published
    27 April 2011
    View recommendations

    Sections for IPG391

  4. Extracorporeal membrane oxygenation (ECMO) for acute heart failure in adults (IPG482)

    Evidence-based recommendations on extracorporeal membrane oxygenation (ECMO) for acute heart failure in adults. This involves using an artificial lung to oxygenate the blood outside the body.

    Interventional procedures guidance
    Published
    27 March 2014
    View recommendations

    Sections for IPG482

  5. NICE encourages further research into efficacy of extracorporeal membrane oxygenation (ECMO) for acute heart failure. This should include clear documentation of patient selection and indications for the use of ECMO. Outcome measures should include survival, quality of life and neurological status.

    Question NICE encourages further research into efficacy of extracorporeal membrane oxygenation (ECMO) for acute heart failure. This...

    Research recommendation
    Published
    9 June 2015

  6. Cytokine adsorption devices for treating respiratory failure in people with COVID-19 (MIB217)

    NICE has developed a medtech innovation briefing (MIB) on cytokine adsorption devices for treating respiratory failure in people with COVID-19 .

    Medtech innovation briefing
    Published
    21 May 2020

  7. CentriMag for heart failure (MIB92)

    NICE has developed a medtech innovation briefing (MIB) on CentriMag for heart failure .

    Medtech innovation briefing
    Published
    18 January 2017

  8. Ex-situ machine perfusion for extracorporeal preservation of lungs (ex-vivo lung perfusion) for transplant (IPG695)

    Evidence-based recommendations on ex-situ machine perfusion for extracorporeal preservation of lungs for transplant. This involves using a machine to deliver an oxygenated solution to a donor lung and keep it at normal body temperature until it can be transplanted.

    Interventional procedures guidance
    Published
    26 May 2021
    View recommendations

    Sections for IPG695

  9. Extracorporeal carbon dioxide removal for acute respiratory failure (IPG776)

    Evidence-based recommendations on extracorporeal carbon dioxide removal for acute respiratory failure. This involves taking blood out of the circulatory system and passing it across a synthetic membrane that allows some of the carbon dioxide in the blood to be removed. The blood is then returned to the circulatory system.

    Interventional procedures guidance
    Published
    15 November 2023
    View recommendations

    Sections for IPG776

  10. NICE encourages further research into the use of innovative technologies for the management of severe acute respiratory failure, and may review this guidance on publication of further evidence.

    explanatory notes(if applicable) Evidence on the safety of extracorporeal membrane oxygenation (ECMO) for severe acute respiratory...

    Research recommendation
    Published
    9 June 2015

  11. What are the possible outcomes for people who are critically ill and have COVID-19-associated pulmonary aspergillosis (CAPA)?

    support (for example, invasive mechanical ventilation or extracorporeal membrane oxygenation [ECMO])• hospitalisation metrics (for...

    Research recommendation
    Published
    17 December 2021

  12. CytoSorb therapy for sepsis (MIB87)

    NICE has developed a medtech innovation briefing (MIB) on CytoSorb therapy for sepsis .

    Medtech innovation briefing
    Published
    29 November 2016

  13. NPi-200 for pupillary light reflex in critical care patients (MIB235)

    NICE has developed a medtech innovation briefing (MIB) on NPi-200 for pupillary light reflex in critical care patients .

    Medtech innovation briefing
    Published
    12 November 2020

  14. Extracorporeal membrane oxygenation in adults (IPG39)

    This guidance has been updated and replaced by NICE interventional procedure guidance 391.

    Interventional procedures guidance
    Published
    1 January 2004

  15. Extra corporeal membrane oxygenation for acute heart failure in children

    Discontinued [GID-IP1153]

    Interventional procedures guidance
    Discontinued